Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial. Ann Surg 2018; 267: 826-832.

Published: 9th August 2018

Authors: Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L et al.


In the study that included 286 patients followed for a median of 55.9 months, three year disease-free survival was 62% after right thoracotomy versus 52% after left thoracotomy (P=0.047). Respective overall survival rates were 74 and 60%, P=0.029.

Pubmed Link

Your comments